Literature DB >> 21331524

Fanconi anemia: a disorder defective in the DNA damage response.

Hiroyuki Kitao1, Minoru Takata2.   

Abstract

Fanconi anemia (FA) is a cancer predisposition disorder characterized by progressive bone marrow failure, congenital developmental defects, chromosomal abnormalities, and cellular hypersensitivity to DNA interstrand crosslink (ICL) agents. So far mutations in 14 FANC genes were identified in FA or FA-like patients. These gene products constitute a common ubiquitin-phosphorylation network called the "FA pathway" and cooperate with other proteins involved in DNA repair and cell cycle control to repair ICL lesions and to maintain genome stability. In this review, we summarize recent exciting discoveries that have expanded our view of the molecular mechanisms operating in DNA repair and DNA damage signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331524     DOI: 10.1007/s12185-011-0777-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  50 in total

1.  FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling.

Authors:  Sarah Luke-Glaser; Brian Luke; Simona Grossi; Angelos Constantinou
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

2.  A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability.

Authors:  Zhijiang Yan; Mathieu Delannoy; Chen Ling; Danielle Daee; Fekret Osman; Parameswary A Muniandy; Xi Shen; Anneke B Oostra; Hansen Du; Jurgen Steltenpool; Ti Lin; Beatrice Schuster; Chantal Décaillet; Andrzej Stasiak; Alicja Z Stasiak; Stacie Stone; Maureen E Hoatlin; Detlev Schindler; Christopher L Woodcock; Hans Joenje; Ranjan Sen; Johan P de Winter; Lei Li; Michael M Seidman; Matthew C Whitby; Kyungjae Myung; Angelos Constantinou; Weidong Wang
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

3.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

4.  Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.

Authors:  Scott Houghtaling; Amy Newell; Yassmine Akkari; Toshiyasu Taniguchi; Susan Olson; Markus Grompe
Journal:  Hum Mol Genet       Date:  2005-08-31       Impact factor: 6.150

5.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair.

Authors:  Agata Smogorzewska; Rohini Desetty; Takamune T Saito; Michael Schlabach; Francis P Lach; Mathew E Sowa; Alan B Clark; Thomas A Kunkel; J Wade Harper; Monica P Colaiácovo; Stephen J Elledge
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

7.  Fanconi anemia proteins stabilize replication forks.

Authors:  Lily Chien Wang; Stacie Stone; Maureen Elizabeth Hoatlin; Jean Gautier
Journal:  DNA Repair (Amst)       Date:  2008-09-25

Review 8.  Fanconi anemia proteins and the s phase checkpoint.

Authors:  Pietro Pichierri; Filippo Rosselli
Journal:  Cell Cycle       Date:  2004-06-08       Impact factor: 4.534

9.  Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links.

Authors:  Irina G Minko; Michael B Harbut; Ivan D Kozekov; Albena Kozekova; Petra M Jakobs; Susan B Olson; Robb E Moses; Thomas M Harris; Carmelo J Rizzo; R Stephen Lloyd
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

10.  Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.

Authors:  Agata Smogorzewska; Shuhei Matsuoka; Patrizia Vinciguerra; E Robert McDonald; Kristen E Hurov; Ji Luo; Bryan A Ballif; Steven P Gygi; Kay Hofmann; Alan D D'Andrea; Stephen J Elledge
Journal:  Cell       Date:  2007-04-05       Impact factor: 41.582

View more
  32 in total

Review 1.  Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.

Authors:  K Scheckenbach; M Wagenmann; M Freund; J Schipper; H Hanenberg
Journal:  Klin Padiatr       Date:  2012-04-13       Impact factor: 1.349

2.  Pluripotent and somatic stem cells: from basic science to utilization in disease modeling and therapeutic application. Meeting report on the 7th International Meeting of the Stem Cell Network North Rhine Westphalia.

Authors:  Stefan Radtke; Peter A Horn
Journal:  Cell Reprogram       Date:  2013-09-10       Impact factor: 1.987

3.  Fanconi anemia group J helicase and MRE11 nuclease interact to facilitate the DNA damage response.

Authors:  Avvaru N Suhasini; Joshua A Sommers; Parameswary A Muniandy; Yan Coulombe; Sharon B Cantor; Jean-Yves Masson; Michael M Seidman; Robert M Brosh
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

4.  Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer.

Authors:  Fukun Guo
Journal:  J Oncobiomarkers       Date:  2014

5.  Histone chaperone activity of Fanconi anemia proteins, FANCD2 and FANCI, is required for DNA crosslink repair.

Authors:  Koichi Sato; Masamichi Ishiai; Kazue Toda; Satoshi Furukoshi; Akihisa Osakabe; Hiroaki Tachiwana; Yoshimasa Takizawa; Wataru Kagawa; Hiroyuki Kitao; Naoshi Dohmae; Chikashi Obuse; Hiroshi Kimura; Minoru Takata; Hitoshi Kurumizaka
Journal:  EMBO J       Date:  2012-07-24       Impact factor: 11.598

6.  RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).

Authors:  Kathrin Scheckenbach; Stephan E Baldus; Vera Balz; Marcel Freund; Petra Pakropa; Christoph Sproll; Karl-Ludwig Schäfer; Martin Wagenmann; Jörg Schipper; Helmut Hanenberg
Journal:  Oral Oncol       Date:  2013-12-06       Impact factor: 5.337

Review 7.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

8.  mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.

Authors:  J Li; W Du; S Zhang; F Guo; M O'Connor; G Thomas; S Kozma; B Zingarelli; Q Pang; Y Zheng
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

9.  Novel FANCI mutations in Fanconi anemia with VACTERL association.

Authors:  Sharon A Savage; Bari J Ballew; Neelam Giri; Settara C Chandrasekharappa; Najim Ameziane; Johan de Winter; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2015-11-21       Impact factor: 2.802

10.  Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.

Authors:  Changxian Shen; Duane Oswald; Doris Phelps; Hakan Cam; Christopher E Pelloski; Qishen Pang; Peter J Houghton
Journal:  Cancer Res       Date:  2013-04-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.